Clinical Study to Evaluate the Efficacy of Lavangadi Samsharkara Churna in the Management of Kaphaja Kasa: A Case Series

Kaphaja Kasa is a Kapha-dominant disorder of Pranavaha Strotas characterized by productive cough, thick expectoration, Peenasa, Aruchi and Agnimandya, clinically resembling conditions such as productive cough and chronic bronchitis. The present clinical study was undertaken to evaluate the efficacy of Lavangadi Samsharkara Churna in the management of Kaphaja Kasa. The study was conducted at SSNJ Hospital, Solapur, and patients aged 18–70 years fulfilling the diagnostic criteria were selected. The formulation was administered in a dose of 2 gm thrice daily in Pashchatbhakta Kala for 15 days, and assessment was done on the 7th and 15th day based on subjective grading of Kasa Vega, Kaphanisthivana, Peenasa, Aruchi and Agnimandya. After completion of therapy, marked improvement was observed in all parameters, with 95% relief in symptoms and no adverse effects during treatment or follow-up. The therapeutic efficacy of Lavangadi Samsharkara Churna can be attributed to its Deepana, Pachana, Kapha Vilayana, Shothahara and bronchodilatory actions, which correct Agnimandya, liquefy and expel Kapha, reduce airway inflammation and improve respiratory function. The study concludes that Lavangadi Samsharkara Churna is a safe, economical and effective formulation in the management of Kaphaja Kasa.